BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37528387)

  • 1. Pharmacovigilance practice among pediatric neurologists from Poland and Germany.
    Kopciuch D; Kus K; Niśkiewicz I; Fliciński J; Zaprutko T; Ratajczak P; Nowakowska E; Hoffmann K; Koligat-Seitz A; Bryl W; Paczkowska A
    BMC Med Educ; 2023 Aug; 23(1):547. PubMed ID: 37528387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.
    Kopciuch D; Kamal NN; Kamal NN; Hamdy NA; Paczkowska A; Zaprutko T; Ratajczak P; Fliciński J; Kus K; Nowakowska E
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
    Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
    Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.
    Mukattash TL; Alwadi MW; Abu-Farha RK; Jarab AS; Al-Zubiedi SA; Alwedyan T
    Curr Clin Pharmacol; 2018; 13(1):45-54. PubMed ID: 29521246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
    Zimmermann A; Gaworska-Krzeminska A; Flis A
    Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the knowledge of and attitudes towards pharmacovigilance among healthcare students in China: a cross-sectional study.
    Zhao Y; Yang L; Tan R; Yuan J
    BMC Med Educ; 2024 May; 24(1):570. PubMed ID: 38789989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance and radiologists: How well do they get along?
    Aydin OC; Aydin S; Guney HZ
    Br J Radiol; 2020 Nov; 93(1115):20200596. PubMed ID: 32903029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance Concept Knowledge, Perspectives and Attitudes: A Cross-Sectional Study Among Community Pharmacists.
    Abu Assab M; Alhamad H; Albahar F; Abu Dayyih W; Echarif S; Abu Assab H
    Inquiry; 2024; 61():469580241246464. PubMed ID: 38581250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitude and practice of physicians and nurses at the cape coast teaching hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting.
    Powell JF; Henneh IT; Ekor M
    PLoS One; 2023; 18(7):e0288100. PubMed ID: 37418384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental reporting of adverse drug reactions in South Africa: An online survey.
    Pillay S; Mulubwa M; Viljoen M
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
    Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
    J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
    Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
    BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' perspectives on adverse drug reactions in pediatric routine care: a survey.
    Neininger MP; Jeschke S; Kiesel LM; Bertsche T; Bertsche A
    World J Pediatr; 2022 Jan; 18(1):50-58. PubMed ID: 34773600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.